Muller & Phipps (India) (BOM:501477) FCF Yield %: 0.87 (As of Jul. 05, 2026)


BOM:501477 Muller & Phipps (India) Ltd BOM:501477
54 GF Score
Price ₹219.95
GF Value ₹280.57
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Muller & Phipps (India) FCF Yield %?

Muller & Phipps (India) BOM:501477 -0.02% 54 FCF Yield % is 0.87 as of Jul. 05, 2026. GuruFocus rates BOM:501477 with a GF Score™ of 54/100 and a GF Value™ of ₹280.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Muller & Phipps (India) ranks worse than 53.74% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Muller & Phipps (India)'s Trailing 12-Month Free Cash Flow is ₹1.19 Mil, and Market Cap is ₹137.47 Mil. Therefore, Muller & Phipps (India)'s FCF Yield % for today is 0.87%.

The historical rank and industry rank for Muller & Phipps (India)'s FCF Yield % or its related term are showing as below:

BOM:501477' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.87
Current: 0.87


During the past 13 years, the highest FCF Yield % of Muller & Phipps (India) was 0.87%. The lowest was 0.00%. And the median was 0.00%.

BOM:501477's FCF Yield % is ranked worse than
53.74% of 681 companies
in the Healthcare Providers & Services industry
Industry Median: 1.83 vs BOM:501477: 0.87

Muller & Phipps (India)'s FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Muller & Phipps (India) FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Muller & Phipps (India) FCF Yield % Related Terms


Muller & Phipps (India) FCF Yield % Historical Data

* Premium members only.

The historical data trend for Muller & Phipps (India)'s FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Muller & Phipps (India) FCF Yield % Chart

Muller & Phipps (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.31 1.86 5.40 -2.11 1.00

Muller & Phipps (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Muller & Phipps (India) FCF Yield % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Muller & Phipps (India) FCF Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s FCF Yield % distribution charts can be found below:

* The bar in red indicates where Muller & Phipps (India)'s FCF Yield % falls into.


BOM:501477
54GF Score
Muller & Phipps (India) Ltd BOM:501477
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Muller & Phipps (India) FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Muller & Phipps (India)'s FCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=1.19 / 119
=1.00%

Muller & Phipps (India)'s annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 119
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.87 mean?
Muller & Phipps (India) (BOM:501477) has a FCF Yield % of 0.87 as of Jul. 05, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Muller & Phipps (India) and its competitors. According to the industry distribution chart, Muller & Phipps (India) ranks #366 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 53.7%.
Is Muller & Phipps (India)'s FCF Yield % too high?
Muller & Phipps (India)'s current FCF Yield % is 0.87. The Healthcare Providers & Services industry median FCF Yield % is 1.83. Muller & Phipps (India)'s value of 0.87 is 52.5% below this industry median. Based on the distribution chart, Muller & Phipps (India) ranks #366 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Muller & Phipps (India) has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Muller & Phipps (India)'s FCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Muller & Phipps (India) ranks #366 out of 681 companies for FCF Yield %. This places Muller & Phipps (India) in the lower half of its industry. The industry median FCF Yield % is 1.83. Muller & Phipps (India)'s value of 0.87 is 52.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Muller & Phipps (India)'s current FCF Yield % of 0.87 is 52.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Muller & Phipps (India) and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Muller & Phipps (India)'s current FCF Yield % is 0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Muller & Phipps (India) stock overvalued right now?
Based on GuruFocus' analysis, Muller & Phipps (India) (BOM:501477) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹280.57, compared to a current price of ₹219.95 — trading 21.6% below its estimated fair value. The current FCF Yield % is 0.87 and 52.5% below the Healthcare Providers & Services industry median of 1.83. Muller & Phipps (India)'s overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Muller & Phipps (India) (BOM:501477), the current FCF Yield % is 0.87 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?

Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued. The current stock price of ₹219.95 is trading 21.6% below its estimated GF Value™ of ₹280.57. GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.

Key valuation signals for BOM:501477:

  • FCF Yield %: 0.87
  • GF Value™: ₹280.57 vs. price of ₹219.95 (21.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs
  • Industry Position: 52.5% below the Healthcare Providers & Services median (#366 of 681)

No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Muller & Phipps (India) Business Description

Address 204, Madhva Commercial Premises, C-4, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
54GF Score

Get the complete analysis for BOM:501477

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹219.95
Price
₹280.57
GF Value